To Evaluate the Efficacy and Safety of SCB01A in Subjects With r/m Squamous Cell Head and Neck Cancer Condition: Head and Neck Neoplasms Intervention: Drug: SCB01A Sponsor: SynCore Biotechnology Co., Ltd. Terminated |
Study of the Combination of Panitumumab With Paclitaxel as First-line Treatment of Subjects With Head and Neck Cancer Condition: Head and Neck Cancer Intervention: Drug: Panitumumab + paclitaxel Sponsors: Grupo Español de Tratamiento de Tumores de Cabeza y Cuello; Amgen; Trial Form Support S.L. Completed |
The Effects on Auditory Function of RADiotherapy and Chemotherapy Treatments for Head and Neck Tumours (EARAD) Conditions: Head and Neck Neoplasms; Hearing Loss Intervention: Sponsor: University of Manchester Not yet recruiting |
A Phase I/II Clinical Trial of PepCan in Head and Neck Cancer Patients Condition: Head and Neck Cancer Intervention: Biological: PepCan Sponsor: University of Arkansas Not yet recruiting |
NUTRI-HAB - Posttreatment Rehabilitation of Nutrition Impact Symptoms in Head and Neck Cancer Survivors Condition: Head and Neck Cancer Intervention: Other: NUTRI-HAB Sponsors: Odense University Hospital; REHPA The Danish Knowledge Centre for rehabilitation and Palliative Care; University of Southern Denmark; University College Copenhagen; Odense Patient Data Explorative Network; Rigshospitalet, Denmark Enrolling by invitation |
Comparison of Endoscopic Visualization and CT Imaging of Head and Neck Cancers With Pathological Validation Study Condition: Head and Neck Cancer Intervention: Sponsor: University Health Network, Toronto Recruiting |
A Trial of Concurrent Radiation Therapy, Cisplatin, and BMX-001 in Locally Advanced Head and Neck Cancer Condition: Head and Neck Cancer Interventions: Drug: BMX-001; Radiation: Radiation Therapy; Drug: Cisplatin Sponsors: BioMimetix JV, LLC; Duke University Recruiting |
Feasibility of Imaging in the Treatment of Patients With Advanced Head and Neck Cancer Condition: Head and Neck Cancer Intervention: Drug: 99mTc-EC-DG Sponsor: University of Chicago Completed |
Sensor-Assisted Prevention of Dehydration in Head and Neck Cancer Patients Condition: Head and Neck Cancer Interventions: Behavioral: Quality of Life Survey; Behavioral: Health Management Surveys; Other: Monitoring Devices; Behavioral: Symptoms Surveys; Behavioral: Device Usability Survey Sponsors: M.D. Anderson Cancer Center; National Cancer Institute (NCI) Active, not recruiting |
Response to Intermittent Pneumatic Compression Therapy in Head and Neck Cancer-Related Lymphedema Conditions: Head and Neck Neoplasms; Head and Neck Lymphedema; Head and Neck Cancer Interventions: Device: Head and neck garments for pneumatic compression device; Drug: NIRFLI with ICG Sponsor: Tactile Medical Completed |
Anapafseos 5 Agios Nikolaos 72100,Crete,Greece,00302841026182,00306932607174,alsfakia@gmail.com
Blog Archive
- ► 2022 (3010)
- ► 2021 (9899)
- ► 2020 (4138)
-
▼
2019
(2429)
-
▼
April
(373)
-
▼
Apr 22
(23)
- Vertigo Clinical Trials
- Tinnitus Clinical Trials
- Medical Research
- ClinicalTrials
- ClinicalTrials : Head and Neck Neoplasms
- Otolaryngology
- Biochemistry
- Auris Nasus Larynx
- Cancer Radiothérapie
- Microbiology
- La radiologia medica
- Voice
- Cytology and Genetics
- Nuclear Medicine and Molecular Imaging
- PharmacoEconomics
- Molecular Diagnosis & Therapy
- Neuroradiology
- Ophthalmology
- Growth Factors and Stem Cells in Dentistry
- Emergencies, Trauma, Shock
- Transfusion Medicine
- Medical Research
- Nursing and Midwifery
-
▼
Apr 22
(23)
-
▼
April
(373)
Αλέξανδρος Γ. Σφακιανάκης
Monday, April 22, 2019
ClinicalTrials : Head and Neck Neoplasms
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment